CJC-1295 with DAC Reconstitution and Storage: Lab Protocol for Research Peptide Handling
Research Notice: This article covers research topics relevant to CJC-1295 with DAC — available from Palmetto Peptides for laboratory use only.
DISCLAIMER: This article is for educational and scientific research reference purposes only. All compounds discussed are not approved by the FDA for use in humans or animals. All data discussed here reflects preclinical animal research or laboratory use. Palmetto Peptides sells these compounds exclusively for in vitro and preclinical laboratory research. Nothing in this article constitutes medical advice.
CJC-1295 with DAC Reconstitution and Storage: Lab Protocol for Research Peptide Handling
Last Updated: May 18, 2026 | Reading Time: Approximately 10 minutes | Author: Palmetto Peptides Research Team
Quick Answer
CJC-1295 with DAC arrives as a lyophilized (freeze-dried) powder and must be reconstituted before use in research protocols. The standard solvent for research applications is bacteriostatic water (0.9% benzyl alcohol), which maintains sterility across multiple draws. Once reconstituted, solutions should be stored at 2 to 8°C and used within 28 to 30 days. Lyophilized vials, by contrast, remain stable for 24 to 36 months at -20°C. Proper handling throughout reconstitution and storage is critical to preserving peptide activity and ensuring reproducible results.
Why Proper Reconstitution Matters in Peptide Research
Peptides are fundamentally different from small-molecule drugs in their sensitivity to physical and chemical stress. Their biological activity depends on maintaining a specific three-dimensional structure — and that structure can be disrupted by temperature extremes, mechanical shear, pH changes, and exposure to air or light. For a research compound like CJC-1295 with DAC, which incorporates a reactive DAC linker as well as a specific amino acid sequence that must preserve its helical structure for GHRH receptor binding, the quality of the reconstitution process directly impacts biological activity in experimental subjects.
A peptide that has been improperly reconstituted — through aggressive mixing, inappropriate solvents, or contamination — may produce reduced GH responses in animal models, introduce confounding variables into study data, or cause unexpected immune reactions in research subjects. Understanding the science behind each step of the reconstitution protocol is what separates rigorous preclinical research from low-quality, irreproducible work.
Required Materials for Reconstitution
Before beginning reconstitution of CJC-1295 with DAC in a laboratory setting, researchers should have the following materials prepared:
- CJC-1295 with DAC vial: Lyophilized powder, sealed under nitrogen or vacuum. Verify the vial is intact and the lyophilized cake is present. See our guide on sourcing quality CJC-1295 with DAC to ensure purity before proceeding.
- Bacteriostatic water (BAC water): 0.9% benzyl alcohol in sterile water for injection. BAC water is available from Palmetto Peptides in research-grade formulation. This is the preferred solvent for multi-draw vials in research settings due to the bacteriostatic preservative activity of benzyl alcohol.
- Insulin syringe or sterile luer-lock syringe: For precise volume measurement of the reconstitution solvent. A 1 mL insulin syringe (U-100 markings) is convenient for typical research vial sizes.
- Alcohol swabs: For swabbing vial rubber stoppers before drawing from or injecting into the vial.
- Calculation tools: Pen and paper or calculator for concentration math (see below).
Selecting the Right Reconstitution Solvent
For CJC-1295 with DAC research vials, bacteriostatic water is the recommended solvent for standard multi-use research applications. The 0.9% benzyl alcohol in BAC water serves as an antimicrobial preservative, inhibiting bacterial and fungal growth across multiple needle punctures of the rubber stopper. This is particularly important in research settings where the same vial may be accessed repeatedly over a period of days to weeks.
Sterile water for injection (without benzyl alcohol) may also be used if the entire vial is intended for single-use, but it provides no antimicrobial protection and should not be used for multi-draw protocols. Acetic acid solutions (commonly used for some other peptides) are not appropriate for CJC-1295 with DAC, as the lower pH may affect the stability of the DAC linker chemistry.
Concentration Calculation Before Reconstitution
One of the most critical steps in peptide preparation is determining the correct volume of solvent to add in order to achieve the desired final concentration. The formula is straightforward:
Final concentration (mg/mL) = Vial mass (mg) ÷ Volume of solvent added (mL)
Or rearranged to find the volume needed:
Volume to add (mL) = Vial mass (mg) ÷ Desired concentration (mg/mL)
Common research reconstitution scenarios:
| Vial Mass | Solvent Added | Final Concentration |
|---|---|---|
| 2 mg | 1.0 mL BAC water | 2.0 mg/mL (2000 mcg/mL) |
| 2 mg | 2.0 mL BAC water | 1.0 mg/mL (1000 mcg/mL) |
| 5 mg | 2.5 mL BAC water | 2.0 mg/mL (2000 mcg/mL) |
| 5 mg | 5.0 mL BAC water | 1.0 mg/mL (1000 mcg/mL) |
| 10 mg | 5.0 mL BAC water | 2.0 mg/mL (2000 mcg/mL) |
Researchers should choose a concentration that allows convenient, accurate volume measurement for the doses used in their specific animal model protocols. Lower concentrations (1 mg/mL) are typically easier to work with in terms of volume measurement precision, especially for murine studies where the volumes involved are small.
Step-by-Step Reconstitution Protocol
The following protocol represents best practices for reconstituting CJC-1295 with DAC in a research laboratory context:
Step 1: Prepare the Work Area
Reconstitution should be performed in a clean, laminar flow hood where possible, or at minimum in a low-traffic area of the laboratory. All surfaces should be wiped down with 70% ethanol before beginning. Wear appropriate PPE (nitrile gloves, lab coat).
Step 2: Allow Vials to Reach Ambient Temperature
If the CJC-1295 with DAC vial has been stored at -20°C, allow it to equilibrate to room temperature (20 to 22°C) for approximately 20 to 30 minutes before reconstitution. Attempting to reconstitute a cold lyophilized powder can result in incomplete dissolution and inconsistent activity. Do not heat the vial to accelerate warming.
Step 3: Swab Both Vial Stoppers
Using a fresh alcohol swab, wipe the rubber stopper of both the CJC-1295 with DAC vial and the BAC water vial. Allow them to air-dry for 30 seconds before proceeding. This prevents alcohol from being carried into either vial by the needle, as alcohol can denature peptides and compromise sterility assurance.
Step 4: Draw the Calculated Volume of BAC Water
Using a sterile syringe, draw the pre-calculated volume of bacteriostatic water. Verify the volume against the syringe markings before proceeding.
Step 5: Introduce BAC Water Into the Peptide Vial — Technique Matters
This is the most technique-sensitive step of reconstitution. Insert the needle into the rubber stopper and direct the flow of BAC water toward the inner wall of the vial — not directly onto the lyophilized powder cake. Slowly release the plunger, allowing the solvent to run down the inner glass wall and gently wet the freeze-dried powder from the sides rather than impacting it directly.
The reason this matters: direct high-velocity impact of liquid onto a lyophilized peptide cake can cause mechanical shearing that disrupts peptide structure. Peptides like CJC-1295 with DAC are not small, robust molecules — their three-dimensional structure is essential for receptor binding activity, and aggressive handling during reconstitution can compromise this.
Step 6: Allow the Peptide to Dissolve Without Agitation
After introducing the solvent, do not shake, vortex, or sonicate the vial. Allow it to sit undisturbed at room temperature for 5 to 10 minutes. Lyophilized peptides dissolve readily in aqueous solvents given adequate time. Gentle, slow circular swirling is acceptable if dissolution appears incomplete after 10 minutes, but vigorous agitation should be avoided throughout.
Step 7: Verify Complete Dissolution
A fully reconstituted CJC-1295 with DAC solution should be clear and colorless to faintly yellow, without visible particulates or turbidity. Any cloudiness, particulate matter, or color change (other than the normal slight amber tint of some peptide solutions) may indicate incomplete dissolution, contamination, or degradation. Do not use a solution that appears abnormal.
Step 8: Label and Date the Vial
Immediately after reconstitution, label the vial with the compound name, concentration, reconstitution date, and expiration date (28 days from reconstitution when using BAC water). Consistent labeling prevents errors in multi-compound research settings.
Storage Requirements for CJC-1295 with DAC
Proper storage is the single most important factor in maintaining the long-term stability and activity of CJC-1295 with DAC. The compound's stability profiles differ substantially between the lyophilized and reconstituted forms.
Lyophilized (Unreconstituted) Storage
| Storage Condition | Expected Stability | Notes |
|---|---|---|
| -20°C (frozen) | 24 to 36 months | Preferred long-term storage; protect from light and moisture |
| 2 to 8°C (refrigerated) | 6 to 12 months | Acceptable for short-term storage; avoid temperature fluctuations |
| Room temperature (20 to 25°C) | Days to weeks only | Not recommended for storage; use only transiently during reconstitution |
Reconstituted Solution Storage
| Storage Condition | Expected Stability (BAC water) | Notes |
|---|---|---|
| 2 to 8°C (refrigerated) | 28 to 30 days | Primary recommendation for multi-draw vials; benzyl alcohol preserves sterility |
| -20°C (frozen aliquots) | 3 to 6 months | Single-use aliquots only; avoid freeze-thaw cycling |
| Room temperature | Hours only | Not suitable; peptide degradation accelerates rapidly |
Critical Storage Don'ts
The following practices will compromise CJC-1295 with DAC stability and should be avoided:
- Repeated freeze-thaw cycles: Each freeze-thaw cycle causes ice crystal formation that can damage peptide structure. If long-term storage of reconstituted solution is needed, divide into single-use aliquots before freezing.
- Direct light exposure: UV and visible light can cause photodegradation of certain amino acid side chains (particularly phenylalanine and tyrosine residues present in the CJC-1295 sequence). Store vials in amber containers or wrapped in foil, and minimize light exposure during handling.
- Temperature excursions: Brief exposure to temperatures above 37°C can accelerate peptide degradation. Reconstituted vials should not be left at room temperature for more than a few hours during a work session.
- Metal contamination: Metal ions (particularly copper and iron) catalyze oxidative degradation of peptides. Use only plastic or glass containers — avoid metal implements in contact with the solution.
Quality Checks Before Use in Research Protocols
Before incorporating a reconstituted CJC-1295 with DAC preparation into animal studies, researchers should conduct the following quality checks:
- Visual inspection: Confirm the solution is clear, colorless to faint yellow, and free of particulates.
- Concentration verification: If the laboratory has access to a peptide-compatible spectrophotometer (UV absorbance at 280 nm can be used for peptides containing aromatic residues), verify concentration against the expected value.
- pH check: CJC-1295 with DAC solutions in BAC water should have a near-neutral pH (approximately 6.5 to 7.5). Significant deviation from this range may indicate degradation or contamination.
- COA review: Before first use from a new lot, review the Certificate of Analysis from the supplier. See our articles on sourcing quality CJC-1295 with DAC and purity standards and quality control for details on what a proper COA should include.
Handling in Animal Model Research
When using reconstituted CJC-1295 with DAC in animal model studies, draw the required volume from the refrigerated vial immediately before use. The subcutaneous route is standard in most published protocols using this compound in rodent models. For guidance on the pharmacokinetic implications of administration route, see our article on CJC-1295 with DAC pharmacokinetics.
Always record the lot number, reconstitution date, concentration, and volume administered for each experimental subject, as this information is essential for interpreting inter-subject variability in GH and IGF-1 responses.
Research-grade CJC-1295 with DAC and bacteriostatic water for reconstitution are both available from Palmetto Peptides for laboratory procurement. For comprehensive background on this research compound, see the complete guide to CJC-1295 with DAC.
Frequently Asked Questions
Why is bacteriostatic water recommended over sterile water for reconstituting CJC-1295 with DAC?
Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits microbial growth and maintains sterility across multiple needle punctures of the vial rubber stopper. In research settings where a single vial is accessed repeatedly over days or weeks, this preservative activity is essential for preventing contamination. Sterile water without benzyl alcohol should only be used for single-draw, single-use preparations.
How should the BAC water be introduced into the peptide vial?
The solvent should be directed toward the inner glass wall of the vial — not dropped directly onto the lyophilized powder cake. Slow, wall-directed introduction minimizes mechanical shearing of the peptide structure. After introducing the solvent, the vial should be left undisturbed for 5 to 10 minutes to allow dissolution; gentle swirling is permissible, but shaking and vortexing are not.
How long is reconstituted CJC-1295 with DAC stable when stored at 2 to 8°C?
When reconstituted with bacteriostatic water and stored consistently at 2 to 8°C protected from light, CJC-1295 with DAC solutions are generally considered stable for 28 to 30 days. Beyond this window, peptide degradation may reduce activity, and fresh reconstitution is advisable.
Can reconstituted CJC-1295 with DAC be frozen for long-term storage?
Yes, but only as single-use aliquots that will not be subjected to further freeze-thaw cycling. Repeatedly freezing and thawing the same solution damages peptide structure through ice crystal formation. If long-term storage of reconstituted material is needed, divide into single-dose aliquots in small vials before freezing at -20°C, then thaw each aliquot only once before use.
What are the signs that a reconstituted CJC-1295 with DAC preparation has degraded?
Signs of potential degradation include visible cloudiness or turbidity, particulate matter in the solution, significant color change (e.g., browning), or a pH significantly outside the neutral range (below 6.0 or above 8.0). Solutions that fail visual inspection should not be used in research protocols, as degraded preparations will produce unreliable experimental results.
Does the DAC modification affect reconstitution requirements compared to non-DAC GHRH analogs?
The DAC linker is reactive toward thiols, which is the chemistry enabling albumin binding in vivo. In the lyophilized state, this reactive group is protected by the dry environment. Once reconstituted, the DAC group becomes available for reaction. This means reconstituted solutions should not be stored in containers with free thiol groups (e.g., some biological buffers containing DTT or beta-mercaptoethanol), as this could react with the DAC group and reduce bioavailability in research subjects.
Is a laminar flow hood required for reconstitution?
A laminar flow hood is strongly recommended for maintaining sterility, particularly for in vivo animal research where contaminated preparations could cause infections or inflammatory responses in research subjects that confound experimental results. If a flow hood is not available, reconstitution should be performed in the cleanest available area of the laboratory using sterile technique, with all surfaces wiped with 70% ethanol before beginning.
Peer-Reviewed Citations
- Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics. 2000;203(1-2):1-60. doi:10.1016/s0378-5173(00)00423-3
- Jetté L, Léger R, Thibaudeau K, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats. Endocrinology. 2005;146(7):3052-3058. doi:10.1210/en.2004-1624
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
- Bhambhani A, Kim C. A brief review of reconstituted proteins: compatibility, stability and administration. International Journal of Pharmaceutical Compounding. 2013;17(5):366-375.
- Kasraian K, DeLuca PP. Thermal analysis of the tertiary butyl alcohol-water system and its implication on freeze-drying. Pharmaceutical Research. 1995;12(4):484-490. doi:10.1023/a:1016226826822
- Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295. Journal of Clinical Endocrinology and Metabolism. 2006;91(3):799-805. doi:10.1210/jc.2005-1536
Final Disclaimer: All compounds discussed are research chemicals not approved by the FDA for human or veterinary use. All content here is for scientific and educational reference only. Palmetto Peptides sells these products exclusively for in vitro and preclinical laboratory research.
Authored by the Palmetto Peptides Research Team | Last Updated: May 18, 2026